{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:26:41Z","timestamp":1772166401999,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","award":["CPSRG19011"],"award-info":[{"award-number":["CPSRG19011"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Australian guidelines recommend that all people aged 50\u201370\u2009years old actively consider taking daily low-dose aspirin (100\u2013300\u2009mg per day) for 2.5 to 5\u2009years to reduce their risk of colorectal cancer (CRC). Despite the change of national CRC prevention guidelines, there has been no active implementation of the guidelines into clinical practice.<\/jats:p>\n                    <jats:p>We aim to test the efficacy of a health consultation and decision aid, using a novel expected frequency tree (EFT) to present the benefits and harms of low dose aspirin prior to a general practice consultation with patients aged 50\u201370\u2009years, on informed decision-making and uptake of aspirin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Approximately five to seven general practices in Victoria, Australia, will be recruited to participate. Patients 50\u201370\u2009years old, attending an appointment with their general practitioner (GP) for any reason, will be invited to participate in the trial. Two hundred fifty-eight eligible participants will be randomly allocated 1:1 to intervention or active control arms using a computer-generated allocation sequence stratified by general practice, sex, and mode of trial delivery (face-to-face or teletrial).<\/jats:p>\n                    <jats:p>There are two co-primary outcomes: informed decision-making at 1-month post randomisation, measured by the Multi-dimensional Measure of Informed Choice (MMIC), and self-reported daily use of aspirin at 6 months. Secondary outcomes include decisional conflict at 1-month and other behavioural changes to reduce CRC risk at both time points.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This trial will test the efficacy of novel methods for implementing national guidelines to support informed decision-making about taking aspirin in 50\u201370-year-olds to reduce the risk of CRC and other chronic diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      The Australian New Zealand Clinical Trials Registry (ANZCTR)\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12620001003965\">ACTRN12620001003965<\/jats:ext-link>\n                      .\u00a0Registered on 10 October 2020.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-021-05365-8","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T05:03:48Z","timestamp":1626325428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["An RCT of a decision aid to support informed choices about taking aspirin to prevent colorectal cancer and other chronic diseases: a study protocol for the SITA (Should I Take Aspirin?) trial"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8510-6351","authenticated-orcid":false,"given":"Shakira","family":"Milton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6655-0940","authenticated-orcid":false,"given":"Jennifer","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finlay","family":"Macrae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patty","family":"Chondros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyndal","family":"Trevena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona M.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4796-6852","authenticated-orcid":false,"given":"Sibel","family":"Saya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Napin","family":"Karnchanachari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kitty","family":"Novy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmody","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javiera Martinez","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Broun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Whitburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"McGill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Marker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Shub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5274-6336","authenticated-orcid":false,"given":"Jon","family":"Emery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"5365_CR1","unstructured":"Introduction: primary prevention - Clinical Guidelines Wiki [Internet]. [cited 14 Aug 2020]. Available from: https:\/\/wiki.cancer.org.au\/australia\/Guidelines:Colorectal_cancer\/Primary_prevention"},{"issue":"9754","key":"5365_CR2","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","volume":"376","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Wilson M, Elwin C-E, Norrving B, Algra A, Warlow CP, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010;376(9754):1741\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(10)61543-7.","journal-title":"Lancet."},{"issue":"4","key":"5365_CR3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jnci\/djn485","volume":"101","author":"BF Cole","year":"2009","unstructured":"Cole BF, Logan RF, Halabi S, Benamouzig R, Sandler RS, Grainge MJ, et al. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst. 2009;101(4):256\u201366. https:\/\/doi.org\/10.1093\/jnci\/djn485.","journal-title":"J Natl Cancer Inst"},{"issue":"9809","key":"5365_CR4","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","volume":"378","author":"J Burn","year":"2011","unstructured":"Burn J, Gerdes AM, MacRae F, Mecklin JP, Moeslein G, Olschwang S, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet. 2011;378(9809):2081\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(11)61049-0.","journal-title":"Lancet."},{"issue":"5","key":"5365_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1136\/heartjnl-2014-306342","volume":"101","author":"RCM van Kruijsdijk","year":"2015","unstructured":"van Kruijsdijk RCM, Visseren FLJ, Ridker PM, Dorresteijn JAN, Buring JE, van der Graaf Y, et al. Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women. Heart. 2015;101(5):369\u201376. https:\/\/doi.org\/10.1136\/heartjnl-2014-306342.","journal-title":"Heart."},{"issue":"16","key":"5365_CR6","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1056\/NEJMoa1800722","volume":"379","author":"JJ McNeil","year":"2018","unstructured":"McNeil JJ, Woods RL, Nelson MR, Reid CM, Kirpach B, Wolfe R, et al. Effect of aspirin on disability-free survival in the healthy elderly. N Engl J Med. 2018;379(16):1499\u2013508. https:\/\/doi.org\/10.1056\/NEJMoa1800722.","journal-title":"N Engl J Med"},{"issue":"16","key":"5365_CR7","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","volume":"379","author":"JJ McNeil","year":"2018","unstructured":"McNeil JJ, Nelson MR, Woods RL, Lockery JE, Wolfe R, Reid CM, et al. Effect of aspirin on all-cause mortality in the healthy elderly. N Engl J Med. 2018;379(16):1519\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1803955.","journal-title":"N Engl J Med"},{"issue":"9759","key":"5365_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","volume":"377","author":"PM Rothwell","year":"2011","unstructured":"Rothwell PM, Fowkes FGR, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011;377(9759):31\u201341. https:\/\/doi.org\/10.1016\/S0140-6736(10)62110-1.","journal-title":"Lancet."},{"issue":"9678","key":"5365_CR9","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","volume":"373","author":"R Collins","year":"2009","unstructured":"Collins R, Peto R, Hennekens C, Doll R, Bubes V, Buring J, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849\u201360.","journal-title":"Lancet."},{"issue":"8","key":"5365_CR10","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.294.8.914","volume":"294","author":"AT Chan","year":"2005","unstructured":"Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. J Am Med Assoc. 2005;294(8):914\u201323. https:\/\/doi.org\/10.1001\/jama.294.8.914.","journal-title":"J Am Med Assoc"},{"issue":"5","key":"5365_CR11","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.amjmed.2010.12.022","volume":"124","author":"ES Huang","year":"2011","unstructured":"Huang ES, Strate LL, Ho WW, Lee SS, Chan AT. Long-term use of aspirin and the risk of gastrointestinal bleeding. Am J Med. 2011;124(5):426\u201333. https:\/\/doi.org\/10.1016\/j.amjmed.2010.12.022.","journal-title":"Am J Med"},{"issue":"7270","key":"5365_CR12","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1136\/bmj.321.7270.1183","volume":"321","author":"S Derry","year":"2000","unstructured":"Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: Meta-analysis. Br Med J. 2000;321(7270):1183\u20137. https:\/\/doi.org\/10.1136\/bmj.321.7270.1183.","journal-title":"Br Med J"},{"key":"5365_CR13","unstructured":"Chubak J, Kamineni A, Buist DSM, Anderson ML, Whitlock EP. Aspirin use for the prevention of colorectal cancer : an updated systematic evidence review for the U . S . Preventive Services Task Force. Evid Synth. 2015;(133):i\u2013116."},{"issue":"1","key":"5365_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/annonc\/mdu225","volume":"26","author":"J Cuzick","year":"2015","unstructured":"Cuzick J, Thorat MA, Bosetti C, Brown PH, Burn J, Cook NR, et al. Estimates of benefits and harms of prophylactic use of aspirin in the general population. Ann Oncol. 2015;26(1):47\u201357. https:\/\/doi.org\/10.1093\/annonc\/mdu225.","journal-title":"Ann Oncol"},{"issue":"6048","key":"5365_CR15","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1126\/science.1191181","volume":"333","author":"D Spiegelhalter","year":"2011","unstructured":"Spiegelhalter D, Pearson M, Short I. Visualizing uncertainty about the future. Science. 2011;333(6048):1393\u2013400.","journal-title":"Science"},{"issue":"689","key":"5365_CR16","doi-asserted-by":"publisher","first-page":"E843","DOI":"10.3399\/bjgp19X706613","volume":"69","author":"P Nguyen","year":"2019","unstructured":"Nguyen P, McIntosh J, Bickerstaffe A, Maddumarachchi S, Cummings KL, Emery JD. Benefits and harms of aspirin to reduce colorectal cancer risk: a cross-sectional study of methods to communicate risk in primary care. Br J Gen Pract. 2019;69(689):E843\u20139. https:\/\/doi.org\/10.3399\/bjgp19X706613.","journal-title":"Br J Gen Pract"},{"issue":"2","key":"5365_CR17","doi-asserted-by":"publisher","first-page":"e042261","DOI":"10.1136\/bmjopen-2020-042261","volume":"11","author":"S Milton","year":"2021","unstructured":"Milton S, McIntosh J, Yogaparan T, Alphonse P, Saya S, Karnchanachari N, et al. Clinicians\u2019 opinions on recommending aspirin to prevent colorectal cancer to Australians aged 50\u201370\u2009years: a qualitative study. BMJ Open. 2021;11(2):e042261. https:\/\/doi.org\/10.1136\/bmjopen-2020-042261.","journal-title":"BMJ Open"},{"key":"5365_CR18","unstructured":"Macrae F, Chetcuti A, Julie Clarke, Emery J, Mark Jenkins, Trevor Lockett, McNeil J, Allan Spigelman, Aung Ko Win, Robyn Woods, Young G, \u201c[Pachter],[NP]\u201d, John Zalcberg, Cancer Council Australia Colorectal Cancer Guidelines Working Party. Clinical question: Aspirin for prevention of colorectal cancer . In: Clinical practice guidelines for the prevention, early detection and management of colorectal cancer. Sydney: Cancer Council Australia. [Version URL: https:\/\/wiki.cancer.org.au\/australiawiki\/index.php?oldid=196954, cited 1 Apr 2021]. Available from: https:\/\/wiki.cancer.org.au\/australia\/Guidelines:Colorectal_cancer"},{"key":"5365_CR19","doi-asserted-by":"crossref","unstructured":"Stacey D, L\u00e9gar\u00e9 F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017","DOI":"10.1002\/14651858.CD001431.pub5"},{"key":"5365_CR20","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1136\/bmj.a979","volume":"337","author":"P Craig","year":"2008","unstructured":"Craig P, Dieppe P, Macintyre S, Mitchie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: The new Medical Research Council guidance. BMJ. 2008;337:979\u201383.","journal-title":"BMJ"},{"issue":"5","key":"5365_CR21","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jclinepi.2008.12.011","volume":"62","author":"KE Thorpe","year":"2009","unstructured":"Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol. 2009;62(5):464\u201375. https:\/\/doi.org\/10.1016\/j.jclinepi.2008.12.011.","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"5365_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.5694\/mja2.50569","volume":"212","author":"L Caly","year":"2020","unstructured":"Caly L, Druce J, Roberts J, Bond K, Tran T, Kostecki R, et al. Isolation and rapid sharing of the 2019 novel coronavirus ( <scp>SARS<\/scp> -CoV-2) from the first patient diagnosed with <scp>COVID<\/scp> -19 in Australia. Med J Aust. 2020;212(10):459\u201362. https:\/\/doi.org\/10.5694\/mja2.50569.","journal-title":"Med J Aust"},{"key":"5365_CR23","doi-asserted-by":"publisher","first-page":"m3350","DOI":"10.1136\/bmj.m3350","volume":"370","author":"P Smith","year":"2020","unstructured":"Smith P. Covid-19 in Australia: most infected health workers in Victoria\u2019s second wave acquired virus at work. BMJ. 2020;370:m3350.","journal-title":"BMJ."},{"key":"5365_CR24","unstructured":"Coronavirus (COVID-19) current situation and case numbers | Australian Government Department of Health [Internet]. [cited 15 Sep 2020]. Available from: https:\/\/www.health.gov.au\/news\/health-alerts\/novel-coronavirus-2019-ncov-health-alert\/coronavirus-covid-19-current-situation-and-case-numbers"},{"key":"5365_CR25","unstructured":"Coronavirus (COVID-19) restrictions Victoria [Internet]. [cited 16 Sep 2020]. Available from: https:\/\/www.vic.gov.au\/coronavirus-covid-19-restrictions-victoria?gclid=CjwKCAjwzIH7BRAbEiwAoDxxTmnjoNOsKQ7uWc-zanZMKbECoe5-r1GkpLNkToRX9wtK1yJHNpGiKRoCnKcQAvD_BwE"},{"key":"5365_CR26","unstructured":"Wright M, Versteeg R, Hall J. General practice. Aust Heal Rev. 2020 Sep 3 [cited 16 Sep 2020]; Available from: http:\/\/www.publish.csiro.au\/?paper=AH20157"},{"key":"5365_CR27","unstructured":"The adoption of telehealth by general practice: initial insights [Internet]. [cited 16 Sep 2020]. Available from: https:\/\/www.acrrm.org.au\/resources\/college\/digital-health"},{"key":"5365_CR28","unstructured":"MBS changes factsheet COVID-19 Temporary MBS Telehealth Services [Internet]. [cited 15 Sep 2020]. Available from: https:\/\/www.health.gov.au\/health"},{"key":"5365_CR29","unstructured":"ANZCTR - Registration [Internet]. [cited 9 Dec 2020]. Available from: https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=375268"},{"key":"5365_CR30","unstructured":"Macrae F, Trevor L, Clarke J, Emery J, Jenkins M, McNeil J, et al. Dietary and lifestyle strategies - clinical guidelines wiki [Internet]. 2017 [cited 9 Dec 2020]. Available from: https:\/\/wiki.cancer.org.au\/australia\/Guidelines:Colorectal_cancer\/Primary_prevention_dietary_and_lifestyle"},{"key":"5365_CR31","doi-asserted-by":"publisher","first-page":"483","DOI":"10.7326\/0003-4819-151-7-200910060-00009","volume":"151","author":"DI Buckley","year":"2009","unstructured":"Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. C-reactive protein as a risk factor for coronary heart disease: A systematic review and meta-analyses for the U.S. preventive services task force. Ann Intern Med. 2009;151:483\u201395 American College of Physicians.","journal-title":"Ann Intern Med"},{"issue":"1","key":"5365_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12911-017-0407-7","volume":"17","author":"JG Walker","year":"2017","unstructured":"Walker JG, Bickerstaffe A, Hewabandu N, Maddumarachchi S, Dowty JG, Jenkins M, et al. The CRISP colorectal cancer risk prediction tool: an exploratory study using simulated consultations in Australian primary care. BMC Med Inform Decis Mak. 2017;17(1):13. https:\/\/doi.org\/10.1186\/s12911-017-0407-7.","journal-title":"BMC Med Inform Decis Mak"},{"key":"5365_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-156","volume-title":"Maximising retention in a longitudinal study of genital Chlamydia trachomatis among young women in Australia","author":"J Walker","year":"2011","unstructured":"Walker J, Fairley CK, Urban E, Chen MY, Bradshaw C, Walker SM, et al. Maximising retention in a longitudinal study of genital Chlamydia trachomatis among young women in Australia. 2011."},{"key":"5365_CR34","unstructured":"Review of the impact of COVID-19 on medical services and procedures in Australia utilising MBS data: Skin, breast and colorectal cancers, and telehealth services. 2020."},{"key":"5365_CR35","volume-title":"Security guide","author":"Zoom Video Communications Inc","year":"2020","unstructured":"Zoom Video Communications Inc. Security guide, vol. 2020. San Jose: Zoom Video Communications Inc; 2020."},{"issue":"1","key":"5365_CR36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s13063-018-2764-7","volume":"19","author":"JG Walker","year":"2018","unstructured":"Walker JG, Macrae F, Winship I, Oberoi J, Saya S, Milton S, et al. The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial. Trials. 2018;19(1):397.","journal-title":"Trials"},{"issue":"1","key":"5365_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0738-3991(02)00089-7","volume":"48","author":"S Michie","year":"2002","unstructured":"Michie S, Dormandy E, Marteau TM. The multi-dimensional measure of informed choice: a validation study. Patient Educ Couns. 2002;48(1):87\u201391. https:\/\/doi.org\/10.1016\/S0738-3991(02)00089-7.","journal-title":"Patient Educ Couns"},{"issue":"5","key":"5365_CR38","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1177\/0272989X07303824","volume":"27","author":"BJ Zikmund-Fisher","year":"2007","unstructured":"Zikmund-Fisher BJ, Smith DM, Ubel PA, Fagerlin A. Validation of the subjective numeracy scale: effects of low numeracy on comprehension of risk communications and utility elicitations. Med Decis Mak. 2007;27(5):663\u201371. https:\/\/doi.org\/10.1177\/0272989X07303824.","journal-title":"Med Decis Mak"},{"key":"5365_CR39","doi-asserted-by":"crossref","unstructured":"Sheridan SL, Draeger LB, Pignone MP, Keyserling TC, Simpson RJ, Rimer B, et al. A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies. BMC Health Serv Res. 2011;11:331.","DOI":"10.1186\/1472-6963-11-331"},{"key":"5365_CR40","unstructured":"Marteau TM, Dphil SM. A measure of informed choice the importance of informed choice."},{"key":"5365_CR41","doi-asserted-by":"crossref","unstructured":"Stacey D, L\u00e9gar\u00e9 F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Vol. 2017, Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2017.","DOI":"10.1002\/14651858.CD001431.pub5"},{"issue":"1","key":"5365_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/0272989X9501500105","volume":"15","author":"AM O\u2019connor","year":"1995","unstructured":"O\u2019connor AM. Validation of a decisional conflict scale. Med Decis Mak. 1995;15(1):25\u201330. https:\/\/doi.org\/10.1177\/0272989X9501500105.","journal-title":"Med Decis Mak"},{"issue":"4","key":"5365_CR43","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/1740774512450098","volume":"9","author":"IR White","year":"2012","unstructured":"White IR, Carpenter J, Horton NJ. Including all individuals is not enough: lessons for intention-to-treat analysis. Clin Trials. 2012;9(4):396\u2013407. https:\/\/doi.org\/10.1177\/1740774512450098.","journal-title":"Clin Trials"},{"key":"5365_CR44","doi-asserted-by":"crossref","unstructured":"Li G, Taljaard M, Van Den Heuvel ER, Levine MA, Cook DJ, Wells GA, et al. An introduction to multiplicity issues in clinical trials: the what, why, when and how. Int J Epidemiol. 2017:746\u201355.","DOI":"10.1093\/ije\/dyw320"},{"key":"5365_CR45","unstructured":"New in Stata 15 | Stata [Internet]. [cited 14 Jan 2021]. Available from: https:\/\/www.stata.com\/stata15\/"},{"key":"5365_CR46","unstructured":"Statistics c=AU; o=Commonwealth of A ou=Australian B of. Main features - SOCIO-ECONOMIC INDEXES FOR AREAS (SEIFA) 2016."},{"key":"5365_CR47","unstructured":"Connell AM. Employing complier average causal effect analytic methods to examine effects of randomized encouragement trials."},{"key":"5365_CR48","unstructured":"Chemopreventive candidate agents - clinical guidelines wiki [internet]. [cited 8 Nov 2019]. Available from: https:\/\/wiki.cancer.org.au\/australia\/Clinical_question:Aspirin_for_prevention_of_colorectal_cancer"},{"issue":"7780","key":"5365_CR49","first-page":"977","volume":"341","author":"SK Smith","year":"2010","unstructured":"Smith SK, Trevena L, Simpson JM, Barratt A, Nutbeam D, McCaffery KJ. A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial. BMJ. 2010;341(7780):977.","journal-title":"BMJ."},{"key":"5365_CR50","doi-asserted-by":"crossref","unstructured":"Mitchell EJ, Ahmed K, Breeman S, Cotton S, Constable L, Ferry G, et al. It is unprecedented: trial management during the COVID-19 pandemic and beyond. Trials. 2020;21:784 BioMed Central Ltd.","DOI":"10.1186\/s13063-020-04711-6"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05365-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-021-05365-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05365-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T05:10:30Z","timestamp":1626325830000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-021-05365-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5365"],"URL":"https:\/\/doi.org\/10.1186\/s13063-021-05365-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-406678\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"assertion":[{"value":"8 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We have obtained ethics approval through the University of Melbourne\u2019s Medicine and Dentistry Human Ethics Sub-Committee 2056513.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"JE, MJ and FM were members of the Cancer Council Australia guideline development group which recommends the use of low dose aspirin for the prevention of CRC.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"452"}}